Neurotherapeutics
A Novel “Molecular Tweezer” Inhibitor of a-Synuclein Neurotoxicity in Vitro and in Vivo
A Predictable Worm: Application of Caenorhabditis elegans for Mechanistic Investigation of Movement Disorders
A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
Accelerating Discovery for Complex Neurological and Behavioral Disorders Through Systems Genetics and Integrative Genomics in the Laboratory Mouse
Alternative Approaches to Modeling Hereditary Dystonias
Animal Models of Neurologic Disorders: A Nonhuman Primate Model of Spinal Cord Injury
Animal Models of Neurological Disorders
Animal Models of Peripheral Neuropathies
CR8, a Selective and Potent CDK Inhibitor, Provides Neuroprotection in Experimental Traumatic Brain Injury
Effects of Olig2-Overexpressing Neural Stem Cells and Myelin Basic Protein-Activated T Cells on Recovery from Spinal Cord Injury
Erratum to: A Novel “Molecular Tweezer” Inhibitor of a-Synuclein Neurotoxicity In Vitro and In Vivo
Genetic Manipulation of Cell Death and Neuroplasticity Pathways in Traumatic Brain Injury
Huntington’s Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease
Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression
Models That Matter: White Matter Stroke Models
Mouse Models of Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
Nonhuman Primate Models of Stroke for Translational Neuroprotection Research
Novel Animal Models of Pediatric Epilepsy
Recovery of MERRF Fibroblasts and Cybrids Pathophysiology by Coenzyme Q10
The Instrumented Fetal Sheep as a Model of Cerebral White Matter Injury in the Premature Infant